Wordt geladen...
Immunotherapy in pancreatic adenocarcinoma—overcoming barriers to response
Pancreatic adenocarcinoma (PAC) remains one of the leading causes of cancer-related death. Despite multiple advances in targeted and immune therapies, the 5-year survival in advanced PAC remains poor. In this review, we discuss some of the unique aspects of the tumor microenvironment (TME) in PAC th...
Bewaard in:
| Gepubliceerd in: | J Gastrointest Oncol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5848027/ https://ncbi.nlm.nih.gov/pubmed/29564181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.01.13 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|